Applications received for new investments since 1 July 2002: As published in the Guidelines for the Pharmacology and Therapeutics Advisory Committee (PTAC) and its Subcommittees 2002, PHARMAC is, from 1 July 2002, making the existence of applications for new investments (including clinical proposals to widen access) publicly known by publishing them (including the name of the applicant) on PHARMAC’s website. As at 6 October 2008 the following applications for new investments had been received: Trade (chemical) names Lumigan (bimatoprost) Actos (pioglitazone hydrochloride) Enbrel (etanercept) Zostrix (capsaicin) cream Zostrix (capsaicin) HP cream Evista (raloxifene hydrochloride) MabThera (rituximab) Date received 15-Jul-02 12-Jul-02 12-Jul-02 20-Sep-02 20-Sep-02 30-Sep-02 9-Oct-02 Presentation Eye Drops (0.03%) Tablets (15/30/45 mg) 25 mg powder 0.025% cream 0.075% cream Tablets (60 mg) Single-use vials of 100 mg/10 ml and 500 mg/50 ml solution PEGASYS: 180 mcg and 135 mcg strength 0.5 ml solution for injection; 200 mg ribavirin tablets Tablets (10 mg and 20 mg) Applicant Allergan New Zealand Limited Eli Lilly and Company (NZ) Limited Wyeth Pty Limited AFT Pharmaceuticals Ltd AFT Pharmaceuticals Ltd Eli Lilly and Company (NZ) Limited Roche Products (New Zealand) Limited Roche Products (New Zealand) Ltd Pegasys with Copegus (Pegylated interferon alpha 2a 14-Oct-02 in combination with ribavirin) Lexapro (aka Cipralex) (escitalopram; s-citalopram) 14-Oct-02 Lundbeck Australia Pty Ltd 7-Oct-02 (FPA) 27-Sept-02 Femidom (the female condom) (Meridian Developments) Durex Avanti (non-latex male condoms) Sep-02 Packs of 3 FPA / Meridian Developments Packs of 5 Durex / SSL International plc A247420 - qA13003 Trade (chemical) names Date received Presentation Packs of 6 Tablets (1 mg) Capsules (100 mg) Tablets (2.5 mg) Injection (25 mg, 37.5 mg and 50 mg strengths) Oral solution (1 mg/ml in 60 ml bottle) and tablets (1 mg in 10) Topical solution (30 ml and 60 ml for Dalacin T, 30 ml for Clinac and Topicil) 4 mg IV infusion Applicant Meridian Developments (representing Crown Agents in NZ) AstraZeneca Limited Novartis New Zealand Limited Novartis New Zealand Limited Janssen-Cilag Pty Ltd Wyeth Pty Limited Sagami (non-latex 27-Sep-02 (polyurethane) male condoms) Arimidex (anastrozole) Glivec (imatinib mesylate STI571) Femara (letrozole) Risperdal Consta (risperidone microspheres) Rapamune (sirolimus) 15-Oct-02 15-Oct-02 15-Oct-02 16-Oct-02 14-Oct-02 Dalacin T, Clinac, Topicil (topical clindamycin phosphate 19-Nov-02 USP 1%) Zometa (zoledronic acid) Glucoval testing strips (blood glucose testing strips) Diovan (valsartan) Co-Diovan (valsartan + hydrochlorothiazide Ezetrol (ezetimibe) Zyprexa (olanzapine) Lamictal (lamotrigine) Diason Scandishake A247420 - qA13003 Pharmacia Limited 12-Jan-03 14-Apr-03 15-Apr-03 15-Apr-03 16-Apr-03 24-Apr-03 28-Apr-03 8-May-03 8-May-03 Novartis New Zealand Limited AFT Pharmaceuticals Ltd Tablets (40, 80 or 160 mg) Tablets (80/15.5, 160/12.5 and 160/25 mg) Tablets (10 mg) Tablets (2.5, 5 and 10 mg) Tablets (5, 25, 50 and 100 mg) Oral supplement / complete diet (1000 ml pack) Oral supplement / complete diet (85 g sachets) Novartis New Zealand Limited Novartis New Zealand Limited Merck Sharpe and Dohme Eli Lilly and Company (NZ) Limited GlaxoSmithKline Nutricia Nutricia Trade (chemical) names Cubitan Forticreme Diasip Minaphlex Renilon 7.5 Nutrini Extra Fortini Fortini Multifibe Loprofin Loprofin Visudyne (verteporfin) ProSure Jevity Plus Jevity Hical Osmolite HN Date received 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 17-Jun-03 29-Aug-03 29-Aug-03 29-Aug-03 29-Aug-03 Presentation Oral supplement (200 ml pack) Oral supplement / complete diet (125 ml tub) Oral supplement / complete diet (200 ml pack) Protein supplement (29 g sachets) Oral supplement (125 ml pack) Oral supplement / complete diet (500 ml pack) Oral supplement / complete diet (200 ml pack) Oral supplement / complete diet (200 ml pack) Breakfast cereal (375 g pack) Low protein drink mix (400 g can) Powder (15 mg) for IV infusion Oral supplement/complete diet (240 ml pack) Oral supplement/complete diet (1000 ml pack) Oral supplement/complete diet (1000 ml and 237 ml pack) Oral supplement/complete diet (1000 ml pack) 1% cream Pre-operative oral supplement (74 g sachets) Applicant Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Novartis New Zealand Ltd. Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited AFT Pharmaceuticals Ltd Novartis New Zealand Ltd. Crystacide (hydrogen peroxide 17-Sep-03 1%) cream Oral Impact A247420 - qA13003 19-Sep-03 Trade (chemical) names TheraTears (carboxymethylcellulose sodium solution) Seroquel (quetiapine) Date received 29-Sep-03 Presentation Eye Drops (0.025%) Applicant Corneal Lens Corporation 6-Oct-03 Tablets (25 mg, 100 mg, 150 mg and 200 mg) AstraZeneca Limited Risperdal Quicklet (risperidone) 7-Oct-03 Tablets (0.5 mg, 1.0 mg and 2.0 mg) Janssen – Cilag Pty Ltd Arcoxia (etoricoxib) 8-Oct-03 Tablets (60 mg, 90 mg and 120 mg) Merck Sharpe and Dohme (New Zealand) Limited Zyprexa Zydis (olanzapine) 13-Oct-03 Wafers (5 mg and 10 mg) Eli Lilly New Zealand Limited Crestor (rosuvastatin) 23-Dec-03 Tablets (10 mg, 20 mg, 40 mg and 80 mg) AstraZeneca Limited Human growth hormone (somatropin) 7-Jan-04 Various New Zealand Society of Endocrinologists Aromasin (exemestane) 8-Jan-04 Tablets (25 mg) Pfizer New Zealand Limited Dilatrend (carvedilol) 13-Jan-04 Tablets (6.25 mg, 12.5 mg, 25 mg) Roche Products (New Zealand) Limited Gemcitabine 16-Jan-04 200 mg or 1g injection Eli Lilly A247420 - qA13003 Trade (chemical) names Date received Presentation Tablets (10 mg and 20 mg) Applicant Lundbeck Australia Pty Ltd Lexapro (escitalopram oxalate) 6-Apr-04 Oxycontin (oxycodone hydrochloride) Symbicort turbuhaler (Budesonide / eformoterol) 8-Apr-04 Tablets (10 mg, 20 mg, 40 mg and 80 mg) Mundipharma Pty Ltd 13-Apr-04 Inhaler (80/4.5μg and 160/4.5μg) AstraZeneca Limited Enbrel (etanercept) 13-Apr-04 25 mg powder Paclitaxel - 100 mg injection and 6 mg/ml solution for infusion Docetaxel – 20 mg and 80 mg injection, and 20 mg / 0.5 ml and 40 mg / ml solution 20 mg tablets 500 mg tablets 250 mg capsules 500 mg vials 1g/5 ml powder 50 mg capsule Wyeth New Zealand Taxanes 13-Apr-04 Clinicians Paroxetine mesylate 16-Apr-04 AFT Pharmaceuticals Mycophenolate mofetil 27-May-04 Roche Thalidomide 31-May-04 Douglas MabThera (rituximab) 4-Jun-04 Single-use vials of 100 mg/10 ml and 500 mg/50 ml solution Clinicians Oxaliplatin 9-July-04 Vials (50 mg and 100 mg) Sanofi-Synthelabo A247420 - qA13003 Trade (chemical) names Memantine Date received 12-July-04 Presentation 10 mg tablets 10 mg/g oral drops solution 3 ml cartridge 10 ml vial 100 IU/ml Applicant Lundbeck Insulin glargine 13-July-04 Aventis Rosuvastatin 23-July-2004 AstraZeneca Docetaxel 28-Sept-04 Vials (20 mg and 80 mg) Aventis Pemexetred 5-Oct-04 500 mg vial Eli Lilly Rapamune (sirolimus) 11-Oct-04 1 mg per ml oral liquid Wyeth Methyl 5-aminolevulinat 11-Oct-04 160 mg/g cream Galderma Hepsera (adefovir dipivoxil) 11-Oct-04 10 mg tablets Gilead Gefitinib 11-Oct-04 250 mg capsules AstraZeneca Etanercept 12-Oct-04 25 mg injection Wyeth A247420 - qA13003 Trade (chemical) names Adalimumab Date received 13-Oct-04 Presentation 50 mg/ml 0.8 ml injection Applicant Abbott Laboratories Methylphenidate ER 13-Oct-04 Tablets (18 mg, 36 mg and 54 mg) Janssen-Cilag Lanreotide acetate 13-Oct-04 Prefilled syringe (60 mg, 90 mg and 120 mg) NZ Medical and Scientific Lexapro (escitalopram oxalate) Combigan (brimonidine tartrate and timolol maleate) Avastin (Bevacizumab) Strattera (Atomoxetine) Reyataz (atazanavir sulfate) Viread (tenofovir disorpoxil fumarate) 23 Dec 04 10mg and 20mg film coated tablets Lundbeck 23 Dec 04 Eye Drops (0.2% and 0.5%) Allergan 23 Dec 04 100mg and 400mg vials Roche 10 Jan 05 10mg, 18mg, 25mg, 40mg, or 60mg capsules Eli Lilly 11 Jan 05 150mg or 200 mg capsules Bristol-Myers Squibb 11 Jan 05 300mg capsules Gilead Tracleer (bosentan) 17 Jan 05 62.5mg and 125mg tablets Actelion Pharmaceuticals Australia and Asia Pacific A247420 - qA13003 Trade (chemical) names Date received Presentation 135 mcg or 180 mcg injection Applicant Roche Products New Zealand Limited Pegasys (pegylated interferon 4 April 05 alpha-2a) Emtiva (emtricitabine) 4 April 05 200 mg capsules Gilead Sciences Pty Ltd Spiriva (tiotropium bromide) 10 April 05 18 mcg capsules (Widening access) Boehringer Ingelheim (NZ) Ltd Atacand (candesartan) 10 April 05 4 mg, 8 mg, 16 mg tablets (Widening access) AstraZeneca Fuzeon (enfuvirtide) 10 April 05 108 mg vials Roche Products New Zealand Ltd Xalacom (latanoprost with timolol maleate) 11 April 05 5 ml bottle containing latanoprost 50mcg/ml and timolol Pfizer New Zealand Ltd maleate 5 mg/ml Clinician (on behalf of New Zealand Liver Transplant Unit) Pegasys (pegylated interferon 15 April 05 alpha-2a) 135mcg or 180mcg injection Zevalin (ibritumomab) 28 April 05 3.2 mg ibritumomab tiuxetan in sodium chloride solution (2 ml) Schering Keppra (levetiracetam) 17 May 05 250mg, 500mg, 1000mg tablets UCB Pharma Xeloda (capecitabine) 17 May 05 150mg, 500mg tablets (Widening access) Roche Products New Zealand Ltd A247420 - qA13003 Trade (chemical) names Zithromax (azithromycin) Date received 7 April 05 Presentation 500 mg tablet (Widening access) Applicant Clinician Group Levemir (insulin detemir) 11 July 05 3ml cartridge Novo Nordisk Eligard (leuprorelin acetate) 11 July 05 7.5mg, 22.5mg, 30mg depots Mayne Pharma Pty Ltd Suboxone (buprenorphine/naloxone) Symbicort (budesonide with eformoterol) 12 July 05 2.5mg/0.5mg, 8mg/2mg sublingual tablet Reckitt Benckiser (NZ) Ltd 12 July 05 Dry Powder Inhaler 100/6 mcg, 200/6 mcg AstraZeneca Finasteride or tamsulosin 2 Sept 05 5 mg tablet (finasteride); 0.4 mg capsule (tamsulosin) Clinicians Androderm (testosterone patches) 21 Sept 05 2.5 mg transdermal patch Mayne Pharma Temodal (temozolomide) 18 Oct 05 5 mg, 20 mg, 100 mg, 250 mg capsules Schering-Plough Herceptin (trastuzumab) 20 Dec 05 150 mg, 440 mg injection Roche Products New Zealand Ltd Kivexa (abacavir with lamivudine) 4 Jan 06 600 mg abacavir with 300mg lamivudine tablet GlaxoSmithKline A247420 - qA13003 Trade (chemical) names Zoladex (goserelin acetate widen access) Date received 4 Jan 06 Presentation 3.6 mg, 10.8 mg injection Applicant AstraZeneca Glucerna SR 20 Jan 06 Diabetic oral supplement 1 Kcal/ml Abbott Nutrition ProSure 20 Jan 06 Oral supplement for use in cancer Abbott Nutrition Jevity, Jevity Plus, Jevity HiCal 20 Jan 06 Adult enteral feed with fibre 1 Kcal/ml, 1.2 Kcal/ml, 1.5 Abbott Nutrition Kcal/ml Adult enteral feed with fibre 1 Kcal/ml and increased protein Promote 20 Jan 06 Abbott Nutrition Elecare 20 Jan 06 Elemental formulas Paediatric enteral feed with fibre 1.0 Kcal/ml; Paediatric enteral feed 1.0 Kcal/ml, 1.5 Kcal/ml; Paediatric oral feed 1.0 Kcal/ml; Paediatric oral feed with fibre 1.0 Kcal/ml Juice style adult oral supplement Abbott Nutrition Pediasure 20 Jan 06 Abbott Nutrition Enlive plus 20 Jan 06 Abbott Nutrition Nutrini Low Energy Multi Fibre 20 Jan 06 Paediatric enteral feed Nutricia Scandishake 20 Jan 06 Oral supplement / complete diet Nutricia A247420 - qA13003 Trade (chemical) names Aldara (imiquimod) Date received 3 April 06 Presentation Cream Sachets 5%, 250 g Applicant 3M Pharmaceuticals Fabrazyme (agalsidase beta) 4 April 06 5 ml and 20 ml vials containing 5 mg and 35 mg Fabrazyme respectively. Genzyme Australasia Tarceva (erlotinib) 3 April 06 25 mg, 100 mg and 150 mg tablets Roche Pharmaceuticals Velcade (bortezomib) 5 April 06 3.5 mg in 10 mg vial – IV injection Janssen-Cilag Eloxatin (oxaliplatin) 7 April 06 50 mg and 100 mg vials - powder for infusion Sanofi Aventis Mycardis (telmisartan) 7 April 06 40 mg and 80 mg tablets Boehringer Ingelheim Jadelle (Levonorgestrel implants) 21 June 2006 Implants, 75 mg Schering Alimta (Pemetrexed disodium) 30 June 2006 Injection, 500 mg Eli Lilly Exjade (deferasirox) 30 June 2006 Tablet 125 mg, 250 mg and 500 mg Novartis Enbrel (Etanercept) 4 July 2006 Injection, 25 mg Wyeth A247420 - qA13003 Trade (chemical) names Certican (everolimus) Date received 4 July 2006 Presentation Tablet 0.25 mg, 0.50 mg, 0.75 mg and dispersible tablet 0.25 mg Applicant Novartis Baraclude (Entecavir) 4 July 2006 Tablet 0.5 mg and 1 mg Bristol-Myers Squibb Flomaxtra (Tamsulosin hydrochloride) 2 October 2006 Capsules 0.4 mg CSL Enbrel (Etanercept) 2 October 2006 Injection 25 mg, 50 mg Wyeth Movicol (Macrogol) 3 October 2006 Sachet 13.125g, Sodium chloride 350.7mg, Sodium bicarbonate 178.5mg, Potassium chloride 46.6mg PharmaMarketing Faslodex (Fulvestrant) 3 October 2006 250 mg / 5 ml solution AstraZeneca Caelyx (Pegylated liposomal doxorubicin) 3 October 2006 Injection 2 mg / ml Schering-Plough Humira (Adalimumab) 6 October 2006 Injection 40 mg / ml Abbott Laboratories Mabthera (Rituximab) 5 Dec 2006 Injection 100 mg, 500 mg Roche Pharmaceuticals Lexapro (Escitalopram oxalate) 5 Dec 2006 Tablet 10 mg, 20 mg Lundbeck A247420 - qA13003 Trade (chemical) names Modavigil (Modafinil) Asasantin (Dipyridamole + aspirin) / Persantin (dipyridamole) Fosamax Plus (Alendronate sodium/cholecalciferol) Date received 6 Dec 2006 Presentation Tablet 100 mg Applicant CSL Biotherapies 6 Dec 2006 Tablet dipyridamole 200mg + aspirin 25mg (Asasantin) Boehringer Ingelheim / dipyridamole 200mg (Persantin) 7 Dec 2006 Tablet 70 mg Merck, Sharp & Dohme Ritalin LA (Methylphenidate) 7 Dec 2006 Tablet 20 mg, 30 mg, 40 mg Novartis Revatio (Sildenafil) 7 Dec 2006 Tablet 20 mg Pfizer Glivec (Imatinib mesylate) 8 Dec 2006 Capsule 100 mg (widening access) Novartis Topamax (Topiramate) 11 Dec 2006 Tablet 25 mg, 50 mg, 100 mg and Capsule 15 mg, 25 mg Janssen-Cilag Sutent (Sunitinib malate) 15 Dec 2006 Capsule 12.5 mg, 25 mg, 50 mg Pfizer Pegatron Combination Therapy (Pegylated interferon with 12 Feb 2007 ribavirin) Paclitaxel 2 March 2007 Powder 100 mcg / 200 mg and Injection / Tablet 180 mcg / 200 mg Solution for infusion 300 mg, 30 mg and Injection 100 mg, 1 mg Clinicians Clinicians A247420 - qA13003 Trade (chemical) names Xolair (omalizumab) Date received 13 March 2007 Presentation Injection 150 mg / 1.2 ml Applicant Novartis Vesicare succinate) Reductil hydrochloride) (solifenacin 13 March 2007 Tablet 5 mg, 10 mg CSL Biotherapies (sibutramine 13 March 2007 Capsule 10 mg, 15 mg Abbott Champix (varenicline) Zofran/Zofran Zydis (ondansetron) and Navoban (tropisetron) Cerazette (desogestrel) 13 March 2007 Tablet 0.5 mg, 1 mg Pfizer 21 March 2007 Ondansetron: tablet/dispersible tablet 4 mg, 8 mg and Clinician Tropisetron: capsule 5 mg 12 April 2007 Tablet 75 mcg Pharmaco Differin (adapalene 0.1%) 11 June 2007 Topical gel and topical cream (30g at 1mg/g) Galderma Australia Sprycel (dasatinib) 11 June 2007 Tablet 20 mg, 50 mg, 70 mg Bristol-Myers Squibb Byetta (exenatide) 11 June 2007 Pre-filled injection pen 5µg (1.2 mL), 10 µg (2.4 mL) Eli Lilly Lucentis (ranibizumab) 12 June 2007 Solution for intravitreal injection 3.0 mg / 0.3 mL Novartis A247420 - qA13003 Trade (chemical) names Bicalutamide-Rex (bicalutamide) Date received 12 June 2007 Presentation Tablet 50 mg Applicant Rex Medical Ltd Humira (adalimumab) 12 June 2007 Injection 40 mg / ml Abbott Laboratories MabThera (rituximab) 10 Sept 2007 Infusion 10 ml, 50 ml NZ Rheumatology Association Roche Pharmaceuticals / Abilify (aripiprazole) 10 Sept 2007 Tablet 10 mg, 15 mg, 20 mg, 30 mg Bristol-Myers Squibb Reandron (testosterone undecanoate) 10 Sept 2007 Injection 1000 mg / 4 ml Bayer-Schering Emend (aprepitant) 11 Sept 2007 Capsule (1 x 125 mg + 2 x 80 mg per pack) Merck Sharp & Dohme Zomig (zolmitriptan) 11 Sept 2007 Nasal spray 5 mg AstraZeneca MabCampath (alemtuzumab) 11 Sept 2007 Infusion 30 mg Bayer-Schering Prezista (darunavir) 11 Sept 2007 Tablet 300 mg Janssen-Cilag Tykerb (lapatinib) 11 Sept 2007 Tablet 250 mg GlaxoSmithKline A247420 - qA13003 Trade (chemical) names High-strength Seretide (Salmeterol xinafoate / fluticasone propionate) Date received 11 Sept 2007 Presentation Applicant Accuhaler 60 doses (fluticasone 500 mcg + salmeterol 50 mcg), Metered dose inhaler 120 doses (fluticasone GlaxoSmithKline 250 mcg + salmeterol 25 mcg) Cartridge 3 ml (25% insulin lispro + 75% insulin lispro protamine suspension) Eli Lilly Humalog Mix25 (insulin lispro) 11 Sept 2007 Glivec (imatinib mesylate) 23 Oct 2007 Capsule 100 mg Novartis Oral Navelbine (vinorelbine) 7 Dec 2007 Soft capsule 20 mg, 30 mg Pierre Fabre Medicament Australia Nexavar (Sorafenib) 7 Dec 2007 Tablet 200 mg Bayer NZ Alphagan P Eye Drops (brimonidine tartrate 0.15%) Lantus SoloStar (insulin glargine) Myfortic (Mycophenolate sodium) 7 Dec 2007 Eye drops 1.5 mg/mL (5 ml bottle) Allergan NZ 7 Dec 2007 Lantus SoloStar pen Sanofi Aventis 7 Dec 2007 Gastro-resistant tablet 180 mg, 360 mg Novartis Zoladex (goserelin acetate) 7 Dec 2007 Injection 3.6 mg AstraZeneca Ganfort (bimatoprost 0.03% and timolol maleate 0.5%) 11 Mar 2008 Eye drops 3 ml bottle Allergan A247420 - qA13003 Trade (chemical) names Zaditen (ketotifen fumarate) Date received 11 Mar 2008 Presentation Applicant Eye drops 0.25 mg/ml 5 ml packs multidose unit, 0.4 ml Novartis Ophthalmics 20 units per pack ml single dose Januvia (sitagliptin) 11 Mar 2008 Tablet 25 mg, 50 mg, 100 mg Merck Sharpe & Dohme Tasigna (nilotinib) 11 Mar 2008 Capsule 200 mg Novartis Lantus (insulin glargine) 11 Mar 2008 Vial10 ml, cartridge 3ml x 5, SoloStar 5 x disposable pen Sanofi Aventis ReVia (naltrexone hydrochloride) Cymbalta (duloxetine hydrochloride) 11 Mar 2008 Tablet 50 mg Clinician letter 3 June 2008 Capsules 30 mg and 60 mg Eli Lilly Sabril (vigabatrin) 3 June 2008 Tablet 500 mg Clinician letter Alimta (pemetrexed disodium) 3 June 2008 500 mg vial 100mg vial Eli Lilly Daivobet (calcipotriol and betamethasone dipropionate) 3 June 2008 Ointment. Betamethasone dipropionate 643µg/g (equivalent to 500 µg/g betamethasone) and calcipotriol CSL biotherapies 50µg/g (as calcipotriol hydrate 52.2µg/g) 3.9 mg patch Hospira Oxytrol (oxybutynin) 3 June 2008 A247420 - qA13003 Trade (chemical) names Humira (adalimumab) Date received 3 June 2008 Presentation Subcutaneous injection 40 mg Applicant Abbott Iodine 3 June 2008 Tablet, at least 150 µg per day Ministry of Health Aclasta (zoledronic acid) 3 June 2008 Bottle for intravenous infusion: 5 mg in 100mL Novartis Novomix (insulin aspart) 3 June 2008 30% insulin aspart and 70% insulin aspart protamine suspension for injection/infusion Novo Nordisk Isentress (raltegravir) 3 June 2008 Tablet 400 mg Merck Sharp & Dohme Exelon (rivastigmine) 3 June 2008 Patches 9 mg and 18 mg Novartis Optium (blood ketones) 3 June 2008 Test stips Medica Pacifica Potassium citrate 3 June 2008 Not specified Clinician letter Leflunomide Glatirmer acetate Interferon beta-1-beta Interferon beta-1-alpha 3 June 2008 Tablets 10 mg, 20 mg, and 100 mg NZ Rheumatology association Multiple Sclerosis Society of NZ; Multiple Sclerosis Treatment Assessments Panel of PHARMAC 9 September 2008 Not specified A247420 - qA13003 Trade (chemical) names Norspan PSA (buprenorphine) Date received 8 September 2008 9 September 2008 9 September 2008 6 September 2008 Presentation Patch 5 mg, 10 mg, and 20 mg Applicant Pharmaco Tredaptive (extended-release nicotinic acid/laropiprant) Tablet 1 g/20 mg Merck Sharp & Dohme Pradaxa (dabigatran etexilate) Capsule 75 mg, 110 mg Boehringer Ingelheim Orencia (abatacept) Vial 250 mg Bristol-Myers Squibb PKU cooler (phenylketoneuria 8 September protein drink) 2008 MSUD Express Cooler (maple 8 September syrup urine disease protein 2008 drink) TYR Cooler (tyrosinaemia protein drink) HCU Cooler (homocystinuria protein drink) PKU gel (phenylketonuria protein drink) 6 October 2008 Drinks 10 g / 87 ml, 15 g / 130 ml, 20 g / 174 ml Vitaflo Australia Drink 15 g / 130 ml Vitaflo Australia Drink 15 g / 130 ml Vitaflo Australia 6 October 2008 Drink 15 g / 130 ml Vitaflo Australia 6 October 2008 Sachet 20 g powder Vitaflo Australia A247420 - qA13003